2021
DOI: 10.1007/s11657-021-00944-3
|View full text |Cite
|
Sign up to set email alerts
|

Bisphosphonate treatment and the risk of atypical femoral fracture among patients participating in a Fracture Liaison Service of a tertiary medical center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Traditionally, first-line treatment for osteoporosis is medication; however, compliance is notoriously poor and efficacy is far from universal. Adverse events, although relatively rare, can be serious (6), and discontinuation of certain medication is associated with rapid bone loss and increased risk of fracture (7,8). Harnessing the natural capacity of bone to optimize its strength through exercise, a therapy with few nonresponders or side effects, is an obvious alternative strategy to manage osteoporosis.…”
mentioning
confidence: 99%
“…Traditionally, first-line treatment for osteoporosis is medication; however, compliance is notoriously poor and efficacy is far from universal. Adverse events, although relatively rare, can be serious (6), and discontinuation of certain medication is associated with rapid bone loss and increased risk of fracture (7,8). Harnessing the natural capacity of bone to optimize its strength through exercise, a therapy with few nonresponders or side effects, is an obvious alternative strategy to manage osteoporosis.…”
mentioning
confidence: 99%
“…As a chronic condition, osteoporosis necessitates long-term management, but patient adherence to long-term drug regimens remains unsatisfactory [ 4 , 5 ]. Additionally, certain therapies have notable adverse effects, ranging from musculoskeletal discomfort to rare but severe complications, such as medication-related osteonecrosis of the jaw (MRONJ) and atypical femoral fractures (AFFs), when used for prolonged use [ 6 , 7 ]. Evaluating the strengths, limitations, and long-term benefit-to-risk ratios of each medication is crucial, as is a specific focus on advancements in long-term and sequential treatment strategies.…”
Section: Introductionmentioning
confidence: 99%